NCT05690854 (STAR) is a clinical trial in Transposition of Great Arteries, sponsored by IRCCS Policlinico S. Donato.

Who is sponsoring NCT05690854?

NCT05690854 is sponsored by IRCCS Policlinico S. Donato.

What condition does NCT05690854 study?

NCT05690854 studies Transposition of Great Arteries.

Is NCT05690854 still recruiting?

NCT05690854 is currently status unknown. Last updated 25 January 2023.

Last reviewed 2023-01-25 · How we verify

NCT05690854: STAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiovascular Magnetic Resonance in Adults With SysTemic Right Ventricle (STAR)

Status unknown Last updated 25 January 2023

What this trial tests

trial in Transposition of Great Arteries in 30 participants. Status unknown.

Timeline

29 November 2022

Primary endpoint
30 June 2025

30 June 2025

Quick facts

Lead sponsor	IRCCS Policlinico S. Donato
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	29 November 2022
Primary completion	30 June 2025
Estimated completion	30 June 2025
Sites	1 location across Italy

Conditions studied

Transposition of Great Arteries — all drugs for Transposition of Great Arteries →

Sponsor

IRCCS Policlinico S. Donato

Who can join

18 and older, any sex, with Transposition of Great Arteries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the study is to explore HFs in SRV, comparing their magnitude and direction with that of subpulmonary RV and systemic LV. As a secondary aim, possible association or correlation will be investigated between SRV energetics and: i) patient functional parameters, e.g., the results from cardiopulmonary exercise test (CPET), ii) patient clinical status, including the occurrence of adverse outcome (a composite of death, hospitalization for heart failure, cardiovascular arrest, sustained arrhythmias).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Transposition of Great Arteries

Currently open trials in the same condition.

NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting

Other IRCCS Policlinico S. Donato trials

Trials by the same sponsor.

NCT07295522 — Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? · Phase 4 · not yet recruiting
NCT07169669 — Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome · not yet recruiting
NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
NCT07402161 — The Signature of Alzheimer's Disease in Subjective Cognitive Decline · recruiting
NCT06294119 — Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05690854 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS Policlinico S. Donato
Last refreshed: 25 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing